Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0738
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells ; volume:92 ; number:4 ; day:3 ; month:2 ; year:2018 ; pages:1507-1524 ; date:4.2018
Archives of toxicology ; 92, Heft 4 (3.2.2018), 1507-1524, 4.2018
- Urheber
-
Nemade, Harshal
- Beteiligte Personen und Organisationen
-
Chaudhari, Umesh
Acharya, Aviseka
Hescheler, Jürgen
Hengstler, Jan G.
Papadopoulos, Symeon
Sachinidis, Agapios
SpringerLink (Online service)
- DOI
-
10.1007/s00204-018-2170-7
- URN
-
urn:nbn:de:101:1-2018060923381327370146
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nemade, Harshal
- Chaudhari, Umesh
- Acharya, Aviseka
- Hescheler, Jürgen
- Hengstler, Jan G.
- Papadopoulos, Symeon
- Sachinidis, Agapios
- SpringerLink (Online service)
Ähnliche Objekte (12)
MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
Control mechanisms of carcinogenesis
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
From bisphenol A to bisphenol F and a ban of mustard due to chronic low-dose exposures?
Essential components of methods papers
Conflict of interest Statements : current dilemma and a possible way forward
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes
Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing
Characterization of pluripotent stem cell derived cardiomyocytes
Characterization of pluripotent stem cell-derived cardiomyocytes
Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells
Toxikologie - Wurzeln und Wandel
MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
Control mechanisms of carcinogenesis
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
From bisphenol A to bisphenol F and a ban of mustard due to chronic low-dose exposures?
Essential components of methods papers
Conflict of interest Statements : current dilemma and a possible way forward
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes
Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing
Characterization of pluripotent stem cell derived cardiomyocytes
Characterization of pluripotent stem cell-derived cardiomyocytes
Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells
Toxikologie - Wurzeln und Wandel
MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
Control mechanisms of carcinogenesis
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
From bisphenol A to bisphenol F and a ban of mustard due to chronic low-dose exposures?
Essential components of methods papers
Conflict of interest Statements : current dilemma and a possible way forward
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes
Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing
Characterization of pluripotent stem cell derived cardiomyocytes
Characterization of pluripotent stem cell-derived cardiomyocytes
Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells